Skip to content

Author

Xiao-Chen Bo

We have 6 of 54 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

CBInformax: bioactivity-aware self-supervised molecular representation learning for molecular property and drug-drug interaction prediction.

It is suggested that incorporating bioactivity similarity during pretraining can enrich molecular representations and improve drug-drug interaction prediction and exhibit enhanced sensitivity in distinguishing structurally similar molecules with subtle chemical differences.

Yan-Peng Zhao, Guowei Zhou, Jingjing Wang et al. · 0 citations
Conference Jul 2026

DILI Prediction Using Molecular Fingerprints and ChemBERTa

Drug-induced liver injury (DILI) is a major cause of drug development failure and post-marketing withdrawal. Accurate computational prediction of hepatotoxicity is hindered by complex biological mechanisms and scarce labeled toxicity data. Although pretrained molecular language models like ChemBERTa perform well in mol...

Wanying Li, Naihan Shi, Song He et al. · 0 citations
Conference Jul 2026

PR-GVAE: Property-Controllable Molecular Generation via Conditional Graph Variational Autoencoder

Molecular generation is a core task in drug discovery. Although existing deep generative models can produce valid molecular structures, they lack precise control over molecular properties such as lipophilicity (logP) and drug-likeness (QED). This paper proposes Property-Regularized Graph Variational Autoencoder (PR-GVA...

Lu Yu, Tianyu Han, Shuyue Men et al. · 0 citations
Review Aug 2026

AI-Driven Drug-Target Interaction Prediction: From Data Representation to Model Design.

A systematic reference for future algorithm design, mechanism exploration, and real-world drug discovery applications for AI-driven DTI prediction methodologies, covering binding theories, task formulations, data representation, model design, translational applications, and unresolved challenges.

Jia-Xuan Hu, Lianlian Wu, Song He et al. · 0 citations
Conference Jul 2026

A Drug-Target Affinity Prediction Model Based on Bayesian Meta-Learning and Uncertainty Fusion

In the early stages of drug discovery, predicting drug-target affinity is a crucial task. Due to the vast scale of genomic and chemical spaces, traditional biological methods are time-consuming, labor-intensive, and resource-demanding. As a result, machine learning-based computational methods have emerged to narrow dow...

Naihan Shi, Yanpeng Zhao, Wanying Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.